Effects of Atorvastatin Treatment on Left Ventricular Diastolic Function in Peritoneal Dialysis Patients (ALEVENT)

Trial Profile

Effects of Atorvastatin Treatment on Left Ventricular Diastolic Function in Peritoneal Dialysis Patients (ALEVENT)

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 03 Aug 2017

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Left ventricular dysfunction
  • Focus Therapeutic Use
  • Acronyms ALEVENT
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 10 Aug 2015 Planned End Date changed from 1 Nov 2012 to 1 Oct 2015 as reported by ClinicalTrials.gov record.
    • 10 Aug 2015 Planned primary completion date changed from 1 Nov 2012 to 1 Oct 2015 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top